Status:
UNKNOWN
Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa
Lead Sponsor:
Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus
Conditions:
Haemophilia
Eligibility:
All Genders
18+ years
Brief Summary
Occurrence of inhibitors to coagulation factor VIII is diagnosed in \~30% patients with haemophilia A. Presence of inhibitor with a titre \>5 BU/ml requires the use of by-passing agents: recombinant a...
Detailed Description
This section is Not applicable
Eligibility Criteria
Inclusion
- patients with acquired haemophilia
- patients with congenital haemophilia A with inhibitor
Exclusion
Key Trial Info
Start Date :
April 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01856751
Start Date
April 1 2014
End Date
June 1 2016
Last Update
December 18 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Katedra i Klinika Hematologii i Transplantologii Gdanski Uniwersytet Medyczny
Gdansk, Poland, 80-952
2
Szpital Uniwersytecki w Krakowie, Oddzial Kliniczny Alergii i Immunologii
Krakow, Poland, 31-501
3
Klinika Hematologii Uniwersytetu Medycznego w Lodzi Wojewodzki Szpital Specjalistyczny im. M. Kopernika
Lodz, Poland, 93-510
4
Centrum Diagnostyczno - Lecznicze INTERLAB
Poznan, Poland, 61-505